Seroconversion of Immunoglobulins to SARS-CoV2 in Patients With Inflammatory Bowel Disease Patients Treated by Biologics.

Fumery, Mathurin; Matias, Clement; Brochot, Etienne

Fumery, Mathurin; Matias, Clement; Brochot, Etienne.

Fumery M; Department of Gastroenterology, Amiens University Hospital, Picardie University, Amiens, France.
Matias C; PériTox Laboratory, Périnatalité & Risques Toxiques, UMR-I 01 INERIS, Picardie Jules Verne University, Amiens, France.
Brochot E; Department of Gastroenterology, Amiens University Hospital, Picardie University, Amiens, France.

J Crohns Colitis ; 14(12): 1792-1793, 2020 Dec 02.

Article in English | MEDLINE | ID: covidwho-663649

Subject(s)

COVID-19/complications; Inflammatory Bowel Diseases/drug therapy; SARS-CoV-2/immunology; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized/therapeutic use; COVID-19/blood; Female; Gastrointestinal Agents/therapeutic use; Humans; Immunoglobulins/blood; Inflammatory Bowel Diseases/complications; Infliximab/therapeutic use; Male; Middle Aged; Seroconversion; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / SARS-CoV-2 / COVID-19 Topics: Long Covid Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged / Young adult Language: English Journal: J Crohns Colitis Journal subject: Gastroenterology Year: 2020 Document Type: Article Affiliation country: Ecco-jcc

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google